p53 gene mutations in human tumor s

19
p53 gene mutations in human tumors L ung (897) 56% A drenal (31) 23% C olon (960) 50% B reast (1536) 22% E sophagus (279) 45% E ndom etrium (224) 22% O vary (386) 44% M esotheliom a (23) 22% Pancreas (170) 44% R enal(102) 19% Skin (220) 44% T hyroid (299) 13% G astric (314) 41% H em atological (1916) 12% H ead & neck (524) 37% C arcinoid (13) 11% B ladder (308) 34% M elanom a (70) 9% Sarcom a (339) 31% Parathyroid (13) 8% Prostate (87) 30% C evix (350) 7% H epatocellular (716) 29% N euroblastom a (212) 1% B rain (456) 25% others (155) 0% Tum or type (n) p53 m utation Tum ortype(n) p53 m utation All tum ors: 37% Greenblatt et al. (1995) Cancer Res. 54:4855 50%

description

p53 gene mutations in human tumor s. 50%. Greenblatt et al. (1995) Cancer Res . 54:4855. p53 and Ink4a are the two most frequently mutated genes in human tumors. The Basic Paradigm of p53 Function. Cellular Stresses (e.g. DNA damage). p53 (high). p53 (low). Apoptosis. - PowerPoint PPT Presentation

Transcript of p53 gene mutations in human tumor s

Page 1: p53 gene mutations in human tumor s

p53 gene mutations in human tumors

Lung (897) 56% Adrenal (31) 23% Colon (960) 50% Breast (1536) 22% Esophagus (279) 45% Endometrium (224) 22% Ovary (386) 44% Mesothelioma (23) 22% Pancreas (170) 44% Renal (102) 19% Skin (220) 44% Thyroid (299) 13% Gastric (314) 41% He matological (1916) 12% He ad & neck (524) 37% Carcinoid (13) 11% Bladder (308) 34% Melanoma (70) 9% Sarc oma (339) 31% Parathyroid (13) 8% Prostate (87) 30% Cevix (350) 7% He patoce llular (716) 29% Neuroblastoma (212) 1% Brain (456) 25% others (155) 0%

Tumor type (n) p53 mutation Tumor ty pe ( n)

p53 mutation

All tumors: 37%

Greenblatt et al. (1995) Cancer Res. 54:4855

50%

Page 2: p53 gene mutations in human tumor s

p53 and Ink4a are the two most frequently mutated genes in human tumors

LocusChromosome location type of alterations

estimated frequency of alterations

p53

INK4a

17p13

9p21

nucleotide substitution

homozygous deletion nucleotide substitution small deletion/insertion promoter methylation

~ 50%

~ 40%

Page 3: p53 gene mutations in human tumor s

p53(low)

p53(high)

Cell cycle arrest Apoptosis

Cellular Stresses(e.g. DNA damage)

The Basic Paradigm of p53 Function

Page 4: p53 gene mutations in human tumor s

The Discovery of p53

Page 5: p53 gene mutations in human tumor s

SV40 large T protein binds to p53

T

53 K

61 2 3 4 5

IPNRS anti-T

Page 6: p53 gene mutations in human tumor s

Li Fraumeni Syndrome

An inherited neoplastic disease with autosomal dominant trait

Characterised by multiple primary neoplasms in children and young adults

A predominance of soft tissue sarcomas (e.g. breast)

Page 7: p53 gene mutations in human tumor s

Li Fraumeni Syndrome:Childhood and Adult Onset Cancers

Page 8: p53 gene mutations in human tumor s

Typical Li Fraumeni Syndrome Pedigree

In approximately 70% of Li-Fraumeni cases, affected family members carry a germline mutation of one allele of the TP53 tumour suppressor gene.

Page 9: p53 gene mutations in human tumor s

Inactivation of p53 in Friend murine erythroleukemia

Page 10: p53 gene mutations in human tumor s

p53 Mutant Mice Develop Cancer

Page 11: p53 gene mutations in human tumor s

p53 Mutations in Human Tumors are Found with HighFrequency In the DNA Binding Domain

In 143 families reported:point mutations (85%)deletions (9%)splice mutations (3.5%) insertions (2%)

Page 12: p53 gene mutations in human tumor s

Ribbon Model Space Filling Model

p53 Binds DNA

The most common mutation changes arginine 248, colored red here. Notice how it snakes into the minor groove of the DNA (shown in blue and green), forming a strong stabilizing interaction. When mutated to another amino acid, this interaction is lost. Other key sites of mutation are shown in pink, including arginine residues 175, 249, 273 and 282, and glycine 245.

Page 13: p53 gene mutations in human tumor s

p53 Binds DNA as a Tetramer

Page 14: p53 gene mutations in human tumor s

p53 Functions in Cell Cycle Checkpoints

Page 15: p53 gene mutations in human tumor s

p53 Mutant Cells Lack Cell Cycle Checkpoint Function

Page 16: p53 gene mutations in human tumor s
Page 17: p53 gene mutations in human tumor s

p53 activates p21 (WAF1)

El-Deiry et al. (1993) Cell 75:817

GM=Dex inducible WT p53DEL=Dex inducible mut p53

Page 18: p53 gene mutations in human tumor s
Page 19: p53 gene mutations in human tumor s